Akanda Corp. (NASDAQ:AKAN – Get Free Report) saw a large decline in short interest in the month of July. As of July 15th, there was short interest totaling 6,244 shares, a decline of 65.7% from the June 30th total of 18,178 shares. Based on an average daily volume of 25,674 shares, the days-to-cover ratio is presently 0.2 days. Currently, 1.4% of the shares of the company are sold short.
Wall Street Analyst Weigh In
Several equities analysts recently issued reports on AKAN shares. Weiss Ratings lowered Akanda from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Monday, May 18th. Wall Street Zen upgraded shares of Akanda from a “strong sell” rating to a “sell” rating in a research note on Saturday. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Akanda currently has a consensus rating of “Sell”.
Check Out Our Latest Report on Akanda
Akanda Stock Performance
Akanda (NASDAQ:AKAN – Get Free Report) last posted its quarterly earnings data on Tuesday, June 9th. The company reported ($317.90) earnings per share for the quarter.
About Akanda
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
See Also
- Five stocks we like better than Akanda
- Middleby Is Betting a Leaner Business Can Unlock More Value
- 3 Value ETFs to Consider as Growth Stocks Lag Behind
- Wintrust: A Quiet Regional Bank Posting Loud Results
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
Receive News & Ratings for Akanda Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akanda and related companies with MarketBeat.com's FREE daily email newsletter.
